In 2018, the world passed a demographic point it had never reached before: people aged 65 and older came to outnumber children under five, and the gap has widened every year since. The Aging Research and Drug Discovery Meeting exists because of that curve.
The 13th edition of ARDD runs October 1 to 3, 2026, at the David Rubenstein Treehouse at Harvard University, opening Boston Longevity Week. LongeVC joins as a sponsor, with our managing partner, Garri Zmudze, speaking and the team on the ground throughout.
For LongeVC, ARDD remains one of the few rooms where the academics running the science, the founders translating it, and the pharma teams who would eventually license it all sit together. That distance between promising aging biology and a therapy reaching a patient is exactly where early-stage capital earns its place.
Learn more about ARDD 2026 here.
The 13th edition of ARDD runs October 1 to 3, 2026, at the David Rubenstein Treehouse at Harvard University, opening Boston Longevity Week. LongeVC joins as a sponsor, with our managing partner, Garri Zmudze, speaking and the team on the ground throughout.
For LongeVC, ARDD remains one of the few rooms where the academics running the science, the founders translating it, and the pharma teams who would eventually license it all sit together. That distance between promising aging biology and a therapy reaching a patient is exactly where early-stage capital earns its place.
Learn more about ARDD 2026 here.